![Sylvie Grégoire](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sylvie Grégoire
Fondateur chez
CERVOMED INC.
Fortune : 5 M $ au 31/05/2026
Profil
Sylvie Louise Grégoire is the founder of EIP Pharma, Inc., founded in 2010, serving as Executive Chairman.
Dr. Grégoire is the founder of CervoMed, Inc., founded in 1995, serving as Director.
Dr. Grégoire currently holds the position of Chairman at Abivax SA since 2024.
Dr. Grégoire is Director at F2G Ltd. since 2021.
Dr. Grégoire is a Member of the Supervisory Board at Shire Orphan Therapies GmbH.
Former positions include President, CEO & Executive Director at GlycoFi, Inc. (2004–2005); Chairman at MetrioPharm AG; Executive Chairman at Takeda Pharmaceutical Co., Ltd. (2006–2007); Chairman at Corvidia Therapeutics, Inc. (2016–2020); Independent Director at Cubist Pharmaceuticals LLC (2006–2011); Director at Thallion Pharmaceuticals, Inc.; Director at CellCarta Biosciences, Inc.; Director at Vifor Pharma Management AG; Director at Novo Nordisk Ltd.; Director at Galenica AG; Director at Revvity, Inc.; Non-Executive Director at Corden Pharma Fribourg SA (2013–2019); Director at IDM Pharma, Inc. (2005–2008); Independent Director at Revvity, Inc. (2015–2024); Independent Director at Novo Nordisk A (2015–2025); Executive Vice President-Technical Operations at Biogen MA, Inc. (2001–2003); Executive Vice President-Business Development at Biogen, Inc. (2001–2003); President at Shire Human Genetic Therapies, Inc. (2007–2013); President-Human Genetic Therapies Division at Shire Plc (2007–2013).
Education includes a doctorate from State University of New York at Buffalo (1986), an undergraduate degree from Université Laval (1984), and an undergraduate degree from Séminaire de Sherbrooke (1980).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CERVOMED INC. 16,16 % | 08/06/2026 | 1 496 578 ( 16,16 % ) | 5 M $ | 31/05/2026 |
Postes actifs de Sylvie Grégoire
| Sociétés | Poste | Début |
|---|---|---|
| CERVOMED INC. | Fondateur | 01/01/1995 |
| ABIVAX | Président | 15/07/2024 |
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Directeur/Membre du Conseil | 01/12/2021 |
EIP Pharma, Inc.
 EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Fondateur | 01/01/2010 |
Shire Orphan Therapies GmbH
 Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Directeur/Membre du Conseil | 27/05/2010 |
Anciens postes connus de Sylvie Grégoire
| Sociétés | Poste | Fin |
|---|---|---|
| NOVO NORDISK A/S | Directeur/Membre du Conseil | 14/11/2025 |
| REVVITY, INC. | Directeur/Membre du Conseil | 23/04/2024 |
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Président | 01/01/2020 |
| VIFOR PHARMA | Directeur/Membre du Conseil | 01/05/2019 |
| ░░░░░ ░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Sylvie Grégoire
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
83
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Develops and manufactures drugs related to immunology, neurobiology and oncology | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Shire Plc /Old/
 Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Revvity, Inc.
 Revvity, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes reagents, analytical instruments and develops software | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
MetrioPharm AG
 MetrioPharm AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products and provides logistical & database services | Health Technology |
Shire Orphan Therapies GmbH
Shire Orphan Therapies GmbH Pharmaceuticals: MajorHealth Technology Develops novel drugs | Health Technology |
State University of New York at Buffalo
 State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GlycoFi, Inc.
 GlycoFi, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
IDM Pharma, Inc.
 IDM Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops cancer treatment products | Health Technology |
Université Laval
 Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thallion Pharmaceuticals, Inc.
 Thallion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops new pharmaceutical products | Health Technology |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Develops human genetic therapies | Health Technology |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
CellCarta Biosciences, Inc.
 CellCarta Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as specialty contract research laboratory | Commercial Services |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceuticals products for the treatment of iron deficiency | Health Technology |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Séminaire de Sherbrooke
 Séminaire de Sherbrooke Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
EIP Pharma, Inc.
EIP Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company focused on developing treatments for neurodegenerative diseases | Health Technology |
Corvidia Therapeutics, Inc.
Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Develops precision cardiovascular therapies | Health Technology |
Galenica AG
 Galenica AG Medical DistributorsDistribution Services Wholesales and retails pharmaceuticals and healthcare products | Distribution Services |
CervoMed, Inc.
 CervoMed, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that develops novel therapies | Commercial Services |
